跳至主要内容
临床试验/TCTR20161008001
TCTR20161008001招募中未知

Comparison of efficacy and safety of 0.01% Bimatoprost and 0.1%Tacrolimus in the treatment of facial vitiligo

Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital0 个研究点目标入组 40 人开始时间: 2016年10月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 Years 至 90 Years(—)
性别
All

入选标准

  • - facial vitiligo patient
  • - other affected vitiligo area less than 2% BSA

排除标准

  • - apply topical steroid within 7 days
  • - on current medication effected skin pigmentation within 2 weeks
  • - on current treatment of vitiligo such as oral medication, NBVUB, PUVA, systemic steriod within 1 month
  • - allergy to bimatoprost and protopic
  • - pregnancy and breast feeding patient
  • - underlying disease: asthma

研究者

发起方
Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital

相似试验

Comparison of efficacy and safety of 0.01%... | 临床试验